61 completed, 16 recruiting, 13 terminated, 8 active not recruiting. 108 Phase 1, 29 Phase 2.
Follow Peripheral Nervous System Neoplasms: new trials by email Literature Review of Peripheral Nervous System Neoplasms trials Research Report on Peripheral Nervous System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST | Phase 1 / Phase 2 | Recruiting | Ankit Mangla, MD | 17 | 2026-08-01 | 2026-08-11 |
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2 | Phase 1 / Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 30 | 2026-07-31 | 2026-07-16 |
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection [89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 40 | 2026-06-15 | 2026-10-01 |
| Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas Cabozantinib Oral Tablet, Selumetinib Oral Capsule - Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 | Recruiting | Girish Dhall, MD | 30 | 2026-06-09 | 2026-10-02 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1) | Phase 1 / Phase 2 | Recruiting | AeRang Kim | 45 | 2026-06-01 | 2026-07-27 |
| Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Recruiting | University of Florida | 27 | 2026-02-11 | 2026-06-30 |
| Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 Imlygic - NF1, Neurofibromatosis | Phase 1 | Recruiting | Johns Hopkins University | 10 | 2026-02-01 | 2026-05-08 |
| A Study of DEG6498 in Participants With Solid Tumors DEG6498 - Malignant Neoplasms | Phase 1 | Recruiting | Degron Therapeutics Co. | 100 | 2025-11-13 | 2026-06-30 |
| Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 Luvometinib Tablets - Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 65 | 2025-06-12 | 2025-06-17 |
| PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas PAS-004 Tablets, PAS-004 Capsule - NF1 Mutation, Neurofibroma Plexiform | Phase 1 | Recruiting | Pasithea Therapeutics Corp. | 56 | 2025-05-30 | 2026-10-28 |
| Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA BNCT, [18F]FBPA - Thoracic Solid Malignant Tumor | Phase 1 / Phase 2 | Enrolling by invitation | Stella Pharma Corporation | 30 | 2025-04-10 | 2025-11-19 |
| Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) Kybella - Neurofibromas, Cutaneous, Neurofibromatosis 1 | Phase 1 | Enrolling by invitation | Massachusetts General Hospital | 15 | 2025-04-08 | 2026-04-22 |
| Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma AAVAnc80-antiVEGF via Akouos Delivery Device - Vestibular Schwannoma | Phase 1 / Phase 2 | Recruiting | Eli Lilly and Company | 27 | 2025-01-17 | 2026-11-04 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| A Study of Avutometinib for People With Solid Tumor Cancers Avutometinib - Refractory Cancer, CNS Tumors | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 3 | 2023-10-20 | 2026-11-04 |
| SPEARHEAD-3 Pediatric Study Afamitresgene autoleucel - Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1 / Phase 2 | Recruiting | USWM CT, LLC | 20 | 2023-09-01 | 2026-08-11 |
| Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors TNG462, Pembrolizumab - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Tango Therapeutics, Inc. | 225 | 2023-05-26 | 2026-09-08 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 48 | 2022-07-06 | 2026-05-19 |
| Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion MRTX1719 - Mesothelioma, Non Small Cell Lung Cancer | Phase 1 | Recruiting | Bristol-Myers Squibb | 336 | 2022-06-09 | 2026-09-02 |
| Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors TNG908 - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Terminated | Tango Therapeutics, Inc. | 110 | 2022-03-23 | 2026-04-15 |
Showing 20 of 108. Sign in to see all of them.
Optic Nerve Glioma (48) · Astrocytoma (46) · Medulloblastoma (43) · Familial ependymoma (40) · Neurofibrosarcoma (35) · Sarcoma (35) · Oligodendroglioma (33) · Choroid Plexus Neoplasms (32) · Central Nervous System Neoplasms (31) · Neuroblastoma (24) · Osteosarcoma (20) · Rhabdoid Tumor (18) · Wilms Tumor (18) · Sarcoma, Synovial (16) · Neuroectodermal Tumors, Primitive, Peripheral (15)
Nervous System Diseases (108) · Nervous System Neoplasms (108) · Neoplasms by Histologic Type (107) · Neoplasms, Nerve Tissue (107) · Neoplasms (102) · Neoplasms by Site (68) · Neuroectodermal Tumors (66) · Neoplasms, Glandular and Epithelial (64) · Neoplasms, Germ Cell and Embryonal (62) · Neoplasms, Neuroepithelial (59) · Nerve Sheath Neoplasms (58) · Neuromuscular Diseases (57) · Peripheral Nervous System Diseases (57) · Cranial Nerve Diseases (54)
Filgrastim (10) · Temozolomide (9) · Carboplatin (8) · AZD 6244 (5) · Ifosfamide (5) · Etoposide (4) · Granulocyte Colony-Stimulating Factor (4) · Radiotherapy (4) · pazopanib (4) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (3) · Busulfan (3) · Cyclophosphamide (3) · Doxorubicin (3) · Irinotecan (3) · Magnetic Resonance Spectroscopy (3)
National Cancer Institute (NCI) (28) · Pediatric Brain Tumor Consortium (8) · Children's Oncology Group (6) · Memorial Sloan Kettering Cancer Center (3) · National Institutes of Health Clinical Center (CC) (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · City of Hope Medical Center (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · OHSU Knight Cancer Institute (2) · Seattle Children's Hospital (2) · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (2) · St. Jude Children's Research Hospital (2) · Tango Therapeutics, Inc. (2) · AeRang Kim (1) · Ankit Mangla, MD (1)
United States (94) · Canada (9) · China (6) · Australia (5) · France (4) · United Kingdom (4) · Denmark (2) · Spain (2) · Austria (1) · Belgium (1) · Germany (1) · Ireland (1) · Japan (1) · Netherlands (1) · Russia (1)
Brigitte C Widemann, M.D. (3) · AeRang Kim, MD, PhD (2) · Elizabeth Fox, MD (2) · Mark W. Kieran, MD, PhD (2) · Susan M. Blaney, MD (2) · Aaron H. Wolfson, MD (1) · Aaron Tward, MD (1) · AeRang Kim, MD (1) · Albiruni Razak, M.D. (1) · Allen R. Chen, MD, PhD, MHS (1) · Amar Gajjar (1) · Ankit Mangla, MD (1) · Anna Pawlowska, MD (1) · Antonio Omuro (1) · Barbara Jean Bambach, MD (1)
PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15592836, PMID 15814645, PMID 16234526, PMID 16533779, PMID 16914576, PMID 17634493, PMID 17941066, PMID 18048828, PMID 18281544, PMID 18281546, PMID 19065567, PMID 19075272, PMID 19088049, PMID 19430790, PMID 20044751, PMID 20049936, PMID 20460632, PMID 21115653, PMID 21764821, PMID 22934754, PMID 23382028, PMID 23554030, PMID 23857966, PMID 25858498, PMID 28029918, PMID 30410720, PMID 31401903, PMID 32089640, PMID 32187457, PMID 33641042, PMID 34321280, PMID 34331515, PMID 35467749, PMID 36375115, PMID 36884302, PMID 37115514, PMID 37400844, PMID 38869947, PMID 39255444, PMID 39756156, PMID 40709016, PMID 41139346, PMID 42394972, PMID 42540436, PMID 9849694
U01CA081457 (9), U01CA097452 (8), P30CA008748 (2), U01CA069856 (2), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA014599 (1), P30CA033572 (1), U10CA180821 (1), UM1CA081457 (1)